Figure 5
From: A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma
(A–F) Calibration curves for the nomogram training data at 6 months (A), 12 months (B), and 18 months (C) and independent validation data at 6 months (D), 12 months (E), and 18 months (F).
